by Bhavani Srinivasan | Nov 19, 2021
European Cross-Border Initiatives:Towards Fair Medicine Deals? 18 January 2022 14:00 - 15:15 CET Online This timely event will explore the challenges and opportunities for cross- border collaborations and focus on concrete recommendations to improve access to...
by European Public Health Alliance | Sep 17, 2021 | Opinion, Statements
On 16 September 2021, Dr Milka Sokolović, Director General of EPHA gave a speech at the 71st session of the WHO Regional Committee for Europe where she emphasized the need for better access to effective, novel, high-priced medicines and how the Oslo Medicines...
by European Public Health Alliance | Sep 13, 2021 | Statements
The COVID-19 pandemic has highlighted the importance of addressing shortages of critical medicines and coordinating clinical trials for the development of new medicines. It has also shown how a lack of transparency on clinical trials threatens to delay the development...
by European Public Health Alliance | Sep 5, 2021 | Statements
Ahead of the publication of the European Commission’s proposal for an operational Health Emergency Preparedness and Response Authority (HERA), to ensure better EU preparedness and response to serious cross border health threats, the European Public Health...
by European Public Health Alliance | Jul 8, 2021 | Opinion
The access to medicines debate in Europe is at a critical juncture. With the pandemic, all issues, old and new, suddenly find a place on the agenda. They range from the prices of medicines, the flexibility of regulatory standards, the quality of innovation, all the...
